期刊文献+

维持性血透患者C反应蛋白水平与心血管疾病关系的临床研究 被引量:3

下载PDF
导出
摘要 目的:探讨维持性血液透析(MHD)患者C反应蛋白(CRP)与心血管疾病的关系。方法:选择血液透析中心治疗的MHD患者96例,记录所有患者的心血管疾病病史、性别、年龄、血压、身高、体重,同时透析前采血查血清CRP、白蛋白、血红蛋白、尿素、血清总胆固醇、低密度脂蛋白、Lp(α)等。随诊2年,评价CRP水平与心血管疾病/死亡的关系。结果:96例患者中有心血管疾病患者64例,无心脑血管疾病患者32例,心血管疾病组的CRP(15.6±4.9)mg/L明显高于无心血管疾病组(4.6±4.2)mg/L,P<0.01。96例患者中有36.5%(35/96)的患者CRP超过正常值(正常值<8mg/L),平均血CRP值(14.5±5.9)mg/L(9.2~28.8mg/L)。CRP升高组的心脑血管疾病发生率及病死率明显高于CRP正常组(P<0.001)。死亡原因多为心力衰竭及脑出血。结论:MHD患者存在慢性炎症状态,慢性炎症状态是心血管疾病和死亡的强预测因素。
出处 《中国中西医结合肾病杂志》 2009年第5期428-429,共2页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 汕头市重点科技计划项目(No.200682)
  • 相关文献

参考文献10

  • 1Panichi V, Migliori M,De Pietro S, et al. C- reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif, 2000,18(3) : 183 - 190.
  • 2Trine M, Helle AS, Vibeke EH, et al. C - reactive protein, dietary ω - 3 fatty acids and the extent of coronary artery disease. Am J Cardiol,2001,88(10):1139- 1142.
  • 3Antonin M,Gotto AM Fr. Role of C- reactive protein in coronary risk reduction foc on primary prevention. Am J Cardiol, 2007,99(5):718 - 725.
  • 4Hans,son GK. Inflammation, atherosclerosis and Coronary arery disease. N Engl J Med,2005,352(16) : 1685 - 1695.
  • 5Zoccali C, MaUamaci F, Tripepi G. Novel cardiovascular risk factors in end - stage renal disease. J Am Soc Nephrol, 2004, 15 (Suppl) :S77 - 880.
  • 6Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic rinal failure. Kidney Int, 1999,55(5):1899 - 1911.
  • 7何敬东,王保和,余爱英,蒋琼.维持性血液透析患者微炎症状态相关因子与左心室重塑的关系[J].中国中西医结合肾病杂志,2008,9(5):448-450. 被引量:6
  • 8邱强,高卓,谢院生,陈香美.血液透析患者血清尿酸与C反应蛋白水平的相关研究[J].中国中西医结合肾病杂志,2008,9(3):228-230. 被引量:7
  • 9汪涛.营养不良-炎症-脉粥样硬化综合征[J].中华肾脏病杂志,2000,16(3):195-196. 被引量:34
  • 10Owen WF, Lowrie EG. C - reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int, 1998,54(2) :627 - 636.

二级参考文献25

  • 1陈江华,何强,徐莹.维持性血液透析患者微炎症状态的认识与防治[J].中华肾脏病杂志,2005,21(2):117-118. 被引量:146
  • 2陈香美,张冬.应重视维持性血液透析患者微炎症状态的认识[J].中国血液净化,2005,4(2):59-61. 被引量:102
  • 3邱强,陈香美,谢院生,魏日胞,吴镝,蔡广研,刘述文.影响IgA肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6):329-331. 被引量:43
  • 4吴华.维持性血液透析患者心血管疾病与微炎症状态[J].中国血液净化,2007,6(5):240-241. 被引量:7
  • 5Wanner C, Metzger T. C - reactive protein a marker for all - cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant, 2002,17 (Suppl 8) : 29 - 32.
  • 6Hakoda M,Masunari N, Yamada M,et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors. J Rheumatol,2005,32(5):906 - 912.
  • 7Kang DH, Park SK, Lee IK, et al. Uric acid - induced C - reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol,2005,16(12):3553 - 3562.
  • 8Ronco C, Bowry S, Tetta C. Dialysis patients and cardiovascular problems: Can technology help solve the complex equation? Blood Purif, 2006,24 ( 1 ) : 39 - 45.
  • 9Kaysen GA.The microninflammatoey state in uremia:Cause and potential consequences.J Am Soc Nephrol,2001,12(7):1549-1557.
  • 10Boenisch O,Ehmke KD,Heddergott A,et al.C-eractive protein and cytokineplasma levels in hemodialysis patients.J Soc Nephrol,2002,15(2):547-551.

共引文献42

同被引文献48

  • 1项志兵,徐旻,梁知,顾仁樾.同型半胱氨酸水平与冠心病中医证型相关性的临床研究[J].中医杂志,2004,45(10):742-742. 被引量:9
  • 2王强,黄绍湘,刘钧超,张以昆.冠心病血瘀证与超敏C-反应蛋白关系的临床探讨[J].广西中医药,2005,28(3):7-8. 被引量:14
  • 3方显明,唐耀平,郑德俊.冠心病血浆同型半胱氨酸与中医证型的相关性[J].中医杂志,2005,46(10):775-776. 被引量:19
  • 4Zuo L, Wang M. Current status of maintenance hemodialysis in Beijing, China. Kidney Int Suppl, 2013,3 ( 2 ) : 167 - 169.
  • 5Takahashi R, Ito Y, Takahashi H, et al. Combined values of ser- um albumin, C - reactive protein and body mass index at dialysis initiation accurately predicts long - term mortality. Am J Neph- rol,2012,36(2) : 136 - 143.
  • 6Amemiya N, Ogawa T, Otsuka K, et al. Comparison of serum al- bumin, serum C -reactive protein, and pulse wave velocity as predictors of the 4 - year mortality of chronic hemodialysis pa- tients. J Atheroscler Thromb,2011,18 ( 12 ) : 1071 - 1079.
  • 7Baradari AG, Emami Zeydi A, Espahbodi F, et al. Evaluation of serum C -reactive prote in level and its related factors in hemo- dialysis patients in Sari, Iran. Pak J Biol Sci, 2011,14 ( 10 ) : 59 - 599.
  • 8Bazeley J, Bieber B, Li Y, et al. C - reactive protein and predic- tion of 1 - year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol,2011,6(10) :2452 -2461.
  • 9Kawaguchi T, Tong L, Robinson BM, et al. C - reactive protein and mortality in hemodialysis patients:the Dialysis Outcomes and Practice Patterns Study( DOPPS). Nephron Clin Pract,2011,117 (2) :167 - 178.
  • 10Helal I,Zerelli L, Krid M, et al. Comparison of c - reactive pro- tein and high - sensitivity c - reactive protein levels in patients on hemodialysis. Saudi J Kidney Dis Transpl,2012,23 (3) :477 - 483.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部